
Society says that without access to shared federal data, cancer research is compromised read on >
Society says that without access to shared federal data, cancer research is compromised read on >
Direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention side effects of the drugs read on >
A major recall of canned tuna sold in dozens of states has been issued amid concerns that a packaging defect could cause “a potentially fatal form of food poisoning,” the manufacturer said in a statement. California-based Tri-Union Seafoods announced a voluntary recall for certain tuna products sold under the Genova®, Van Camp’s®, H-E-B and Trader Joe’s brand names, according to the U.S. Food and Drug Administration (FDA). The affected cans may have a faulty pull-tab lid, which could allow them to become contaminated with the Clostridium botulinum bacterium, which causes botulism. While Tri-Union Seafoods has said no illnesses linked to the recalled products had been reported, the company warned consumers not to use the product, “even if it does not look or smell spoiled.” The recalled tuna was distributed to stores in dozens of states across the U.S., including: H-E-B label: Stores in Texas. Trader Joe’s label: Stores in Delaware, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Virginia, Washington, D.C., and Wisconsin. Genova 7-ounce cans: Costco stores in Florida and Georgia. Genova 5-ounce cans: Harris Teeter, Publix, H-E-B, Kroger, Safeway, Walmart and independent retailers in Alabama, Arkansas, Arizona, California, Florida, Georgia, North Carolina, New Jersey, Tennessee and Texas. Van Camp’s label: Walmart and independent retailers in Pennsylvania, Florida and New Jersey. Botulism poisoning is… read on > read on >
A federal judge has ordered the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) to restore access to public health websites that were removed or modified in response to a Trump administration executive order on gender. The order, issued Feb. 11 by U.S. District Judge John Bates, grants a temporary restraining order requested by Doctors for America, a nonprofit group that sued the administration over the website removals. The affected sites, some of which have been online for decades, contain public health information on HIV prevention, youth health risks, fertility treatments and more. The ruling states that the two health agencies removed the sites without explanation and likely violated federal law. “By removing long relied upon medical resources without explanation, it is likely that … each agency failed to ‘examine the relevant data and articulate a satisfactory explanation for its action,’ ” Bates wrote. He ordered the CDC and FDA to restore access by the day’s end Tuesday, a process that staff members were scrambling to complete. “It was a double waste for us because we took them offline, put some of them back, edited others and now are putting it back again,” a federal health official who wanted to remain anonymous told The Washington Post. The removed sites included: The CDC’s guidelines for HIV and PrEP, a medication… read on > read on >
More than 800,000 U.S. children have what’s called “high threshold” peanut allergy, meaning they can tolerate about half a peanut daily before symptoms arise. New research suggests that exposing these kids to tiny but gradually increasing levels of store-bought peanut butter might help ease the allergy for good. “Our study results suggest a safe, inexpensive and effective pathway for allergists to treat children with peanut allergy who can already tolerate the equivalent of at least half a peanut, considered a high-threshold peanut allergy,” said study lead author Dr. Scott Sicherer, chief of allergy and immunology at Mount Sinai in New York City. He believes the findings could have implications for food allergies in general. “Our findings open the gateway to personalized threshold-based treatments of food allergy,” Sicherer said in a Mount Sinai news release, adding that the approach could “be a game-changer for the majority of people with food allergies.” The new trial was funded by the U.S. National Institute of Allergy and Infectious Diseases and published Feb. 10 in NEJM Evidence. For some children and adults, even minuscule amounts of peanut can trigger severe reactions, including life-threatening anaphylaxis. These cases — in which the amount of exposure needed is under half a peanut — are deemed to be “low-threshold” allergies. The U.S. Food and Drug Administration (FDA) recently approved treatments, such as an injected… read on > read on >
Appalachia has a rich history and gorgeous landscapes, but it has also experienced rates of cancer incidence and death that outstrip those of much of the rest of America. However, new data offer hope to the 26 million people living in the region: Cancer rates are falling, although not as steeply as elsewhere in America. Still, “there are reasons for hope and opportunities to increase access to preventive care in at-risk populations throughout Appalachia,” said study senior author Dr. B. Mark Evers, who directs the Markey Cancer Center at the University of Kentucky. He believes experts can “learn from this data where to focus on some of these problems that have been persistent for decades.” The new data were published Feb. 6 in the Journal of the American College of Surgeons. The research team defined Appalachia as 423 counties across 13 states near the eastern seaboard, from Mississippi to southern New York. Evers and colleagues looked at data on cancer incidence and death for the region from 2004 through 2021. The data came from sources such as the U.S. Census Bureau, the U.S. Cancer Statistics Incidence Analytics Database and the National Center for Health Statistics. Some of the findings were grim: For example, between 2017 and 2021, Americans living in Appalachia were 5.6% more likely to be diagnosed with cancer and 12.8% more likely to… read on > read on >